Long-Term Debt (Annual)

Long-Term Debt: The sum of all long term debt fields.

iRadimed Corporation (IRMD) Long-Term Debt data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$83.81M
Net Income	$22.48M
Cost of Goods Sold	$19.49M
Gross Profit	$64.32M
Operating Expenses	$57.67M
Operating Income	$26.15M
Non-Operating Income/Expense	$2.21M
Pre-Tax Income	$28.36M
Normalized Pre-Tax Income	$28.36M
Income after Taxes	$22.48M
Income from Continuous Operations	$22.48M
Consolidated Net Income/Loss	$22.48M
Normalized Income after Taxes	$22.48M
EBIT	$26.15M
EBITDA	$27.31M
Weighted-Average Shares Outstanding (Basic)	12.72M
Weighted-Average Shares Outstanding (Diluted)	12.85M
Earnings per Share (EPS) (Basic)	$1.77
Earnings per Share (EPS) (Diluted)	$1.75
Balance Sheet Financials
Current Assets	$81.20M
Property, Plant, and Equipment	$23.86M
Long-Term Assets	$27.48M
Total Assets	$108.78M
Current Liabilities	$10.18M
Long-Term Debt	--
Long-Term Liabilities	$3.98M
Total Liabilities	$14.16M
Common Equity	$94.62M
Tangible Shareholders Equity	$91.23M
Shareholders Equity	$94.62M
Common Shares Outstanding	12.78M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$24.95M
Cash Flow from Investing Activities	$-8.42M
Cash Flow from Financial Activities	$-17.60M
Beginning Cash	$52.23M
End Cash	$51.16M
Increase/Decrease in Cash	$-1.07M
Stock-Based Compensation	$2.92M
Common Stock Dividends Paid	$-15.04M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.98
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	76.75%
Operating Margin	31.20%
EBIT Margin	31.20%
EBITDA Margin	32.59%
Pre-Tax Profit Margin	33.84%
Profit Margin	26.82%
Free Cash Flow	$16.53M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.77
Inventory Turnover	1.68
Receiveable Turnover	6.13
Days Sales in Receivables	59.52
Return on Equity	23.76%
Return on Tangible Equity	24.64%
Return on Assets	20.67%
Return on Investments	23.76%
Book Value Per Share	$7.40
Free Cash Flow per Share	$1.29
Operating Cash Flow per Share	$1.94

Data from Zacks Investment Research, Inc.